• Sanofi/Takeda, UniQure & CSL, Fog Pharma, Merck + Imago

  • 2022/11/30
  • 再生時間： 9 分
  • ポッドキャスト

Sanofi/Takeda, UniQure & CSL, Fog Pharma, Merck + Imago

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Vaccine hesitancy, the most expensive gene therapy in the world, a $178M series D, and a $1.3B buyout

    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    Sanofi/Takeda
    UniQure & CSL
    Fog Pharma
    Merck + Imago

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 
    続きを読む 一部表示

あらすじ・解説

Vaccine hesitancy, the most expensive gene therapy in the world, a $178M series D, and a $1.3B buyout

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Sanofi/Takeda
UniQure & CSL
Fog Pharma
Merck + Imago

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 
続きを読む 一部表示

Sanofi/Takeda, UniQure & CSL, Fog Pharma, Merck + Imagoに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。